Impact of Time Restricted Feeding on Daily Protein Requirements
NCT ID: NCT05610644
Last Updated: 2024-12-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
61 participants
INTERVENTIONAL
2023-03-29
2024-10-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TRF of RDA
A time-restricted model of consumption of the RDA of protein/day.
isocaloric, isonitrogenous meals
Participants will eat prepared study meals for 3 days that have either the RDA of protein per day or twice the RDA of protein per day.
TRAD of RDA
A typical American dietary ingestion pattern of the RDA of protein/day.
isocaloric, isonitrogenous meals
Participants will eat prepared study meals for 3 days that have either the RDA of protein per day or twice the RDA of protein per day.
TRF of 2RDA
A time-restricted model of consumption of twice the RDA of protein/day.
isocaloric, isonitrogenous meals
Participants will eat prepared study meals for 3 days that have either the RDA of protein per day or twice the RDA of protein per day.
TRAD of 2RDA
A typical American dietary ingestion pattern of twice the RDA of protein/day.
isocaloric, isonitrogenous meals
Participants will eat prepared study meals for 3 days that have either the RDA of protein per day or twice the RDA of protein per day.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
isocaloric, isonitrogenous meals
Participants will eat prepared study meals for 3 days that have either the RDA of protein per day or twice the RDA of protein per day.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. BMI 20-30 kg/m2 inclusive.
3. Capable of providing informed consent.
4. COVID-19 negative and/or asymptomatic
Exclusion Criteria
2. Body mass index \<20 or \>30.
3. Hemoglobin \<10g/dL at screening.
4. Platelets \<150,000/uL at screening.
5. History of diabetes.
6. History of chemotherapy or radiation therapy for cancer in the 6 months prior to enrollment.
7. History of gastrointestinal bypass/reduction surgery.
8. History of a chronic inflammatory disease (e.g. what?)
9. Currently receiving androgen (e.g., testosterone) or anabolic (e.g., GH, IGF-I) therapy.
10. Currently using prescription blood thinning medications.
11. Currently using corticosteroid medications.
12. Unable or unwilling to suspend aspirin use for 7 days prior to Visit 3.
13. Unwilling to avoid using protein or amino-acid supplements during participation.
14. Subjects who are unwilling to fast overnight.
15. Participating in \>200 minutes/week of vigorous exercise and/or \>4 days/week of resistance training.
50 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Arkansas
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Church
Role: PRINCIPAL_INVESTIGATOR
UAMS (University of Arkansas for Medical Sciences)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
275081
Identifier Type: -
Identifier Source: org_study_id